The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications. [electronic resource]
Producer: 20160208Description: 609-23 p. digitalISSN:- 1365-2362
- Adaptor Proteins, Signal Transducing
- Animals
- Antineoplastic Agents -- therapeutic use
- Apoptosis Regulatory Proteins
- Carcinogenesis -- metabolism
- Carcinoma, Hepatocellular -- drug therapy
- Humans
- Intracellular Signaling Peptides and Proteins -- physiology
- Liver Neoplasms -- drug therapy
- MAP Kinase Signaling System -- physiology
- Membrane Proteins -- physiology
- Mice
- Mitogen-Activated Protein Kinases -- metabolism
- Monomeric GTP-Binding Proteins -- physiology
- Mutation -- genetics
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Rats
- Sorafenib
- Tumor Suppressor Proteins -- physiology
- raf Kinases -- metabolism
- ras GTPase-Activating Proteins -- antagonists & inhibitors
- ras Proteins -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.